Want to join the conversation?
$BIIB said the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for marketing authorization of FLIXABI (infliximab). Previously known as SB2, FLIXABI is infliximab biosimilar candidate referencing Remicade, which was developed by Samsung Bioepis, the JV between Samsung BioLogics and $BIIB.
$SBUX launched its annual “Starbucks for Life” competition in the U.S. and Canada. The winner of the competition will receive a credit of one drink or food item per day for a duration of 30 years.
$T shares rose 1.8%, as a big boost for the S&P 500. The company said its new streaming television service DirectTV has so far exceeded expectations.
$TXMD flying high.. anyone here to catch..?
$CMG crashing. There seems to be nothing good to read about this company.